We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
12 quarters
Top 10 Avg Time Held
12 quarters
Top 20 Avg Time Held
10.4 quarters

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AME icon
276
Ametek
AME
$57.3B
$5.17M 0.05%
31,033
-359
-1% -$62K
2020 Q2
16 quarters
HUBS icon
277
HubSpot
HUBS
$11.1B
$5.17M 0.05%
8,766
+342
+4% +$210K
2020 Q2
16 quarters
ULTA icon
278
Ulta Beauty
ULTA
$24.2B
$5.14M 0.05%
13,326
-614
-4% -$250K
2020 Q2
16 quarters
ALNY icon
279
Alnylam Pharmaceuticals
ALNY
$30.4B
$5.12M 0.05%
21,076
+1,378
+7% +$218K
2020 Q2
16 quarters
BR icon
280
Broadridge
BR
$18.8B
$5.09M 0.05%
25,853
+1,054
+4% +$209K
2020 Q2
16 quarters
ACGL icon
281
Arch Capital
ACGL
$33.2B
$5.06M 0.05%
50,113
-5,509
-10% -$536K
2021 Q2
12 quarters
NUE icon
282
Nucor
NUE
$57.3B
$5.02M 0.05%
31,773
-1,100
-3% -$191K
2020 Q2
16 quarters
PEG icon
283
Public Service Enterprise Group
PEG
$35.3B
$5M 0.05%
67,838
-153
-0.2% -$10.9K
2020 Q2
16 quarters
BKR icon
284
Baker Hughes
BKR
$55.7B
$4.95M 0.05%
140,677
-2,389
-2% -$78.4K
2020 Q2
16 quarters
TEAM icon
285
Atlassian
TEAM
$52.4B
$4.94M 0.05%
27,913
+866
+3% +$155K
2022 Q4
6 quarters
VEEV icon
286
Veeva Systems
VEEV
$47.7B
$4.91M 0.05%
26,856
+119
+0.4% +$23.6K
2020 Q2
16 quarters
NTAP icon
287
NetApp
NTAP
$46.8B
$4.89M 0.05%
37,971
+1,234
+3% +$139K
2020 Q2
16 quarters
BIIB icon
288
Biogen
BIIB
$34.1B
$4.89M 0.05%
21,081
+45
+0.2% +$9.78K
2020 Q2
16 quarters
LEN icon
289
Lennar Class A
LEN
$17.8B
$4.87M 0.05%
33,536
-453
-1% -$68.9K
2020 Q2
16 quarters
GIS icon
290
General Mills
GIS
$17.5B
$4.84M 0.05%
76,515
-2,098
-3% -$144K
2020 Q2
16 quarters
GEHC icon
291
GE HealthCare
GEHC
$30.6B
$4.82M 0.05%
61,879
+3,004
+5% +$245K
2023 Q1
5 quarters
KDP icon
292
Keurig Dr Pepper
KDP
$44.5B
$4.82M 0.05%
144,260
+2,727
+2% +$90.5K
2021 Q2
12 quarters
EXC icon
293
Exelon
EXC
$43.4B
$4.81M 0.05%
138,857
-6,737
-5% -$249K
2020 Q2
16 quarters
AXON icon
294
Axon Enterprise
AXON
$33.8B
$4.76M 0.05%
16,178
+503
+3% +$150K
2020 Q2
16 quarters
ED icon
295
Consolidated Edison
ED
$39.7B
$4.73M 0.05%
52,936
+7
+0% +$649
2020 Q2
16 quarters
KVUE icon
296
Kenvue
KVUE
$34.1B
$4.73M 0.05%
260,072
-27,074
-9% -$525K
2023 Q3
3 quarters
EFX icon
297
Equifax
EFX
$17.3B
$4.72M 0.05%
19,481
-5,918
-23% -$1.41M
2020 Q2
16 quarters
TPL icon
298
Texas Pacific Land
TPL
$25.2B
$4.7M 0.05%
19,197
-135
-0.7% -$28.3K
2021 Q2
12 quarters
HIG icon
299
Hartford Financial Services
HIG
$35.3B
$4.68M 0.05%
46,526
+276
+0.6% +$27.7K
2020 Q2
16 quarters
PINS icon
300
Pinterest
PINS
$12.1B
$4.67M 0.05%
105,895
+834
+0.8% +$32.9K
2020 Q2
16 quarters

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.